News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer


9/28/2007 11:33:44 AM

STOCKHOLM, Sweden, September 26, 2007. Swedish MPA gives go ahead for the clinical trial of Affibody’s molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES